baber/WOPTO huggingface dataset:
Patent NZ-556398-A (NZ)
Title: Leaf spring assembly having full leaf leaf spring component and half leaf leaf spring component
Inventor: WILSON WILLIAM
IPC: B60G11/02
Filed: 2001-02-23
Abstract: Disclosed is a leaf spring for use in a vehicle suspension system with a half leaf spring fitted so as to convert the symmetrical leaf spring assembly to an asymmetrical leaf spring assembly. The half leaf spring extends over all of the front leaf cantilever portion of the symmetrical leaf spring assembly and also extends at least partially with the rear cantilever portion.
Patent NZ-560698-A (NZ)
Title: Acidified chlorite disinfectant compositions with olefin stabilizers
Inventor: MORELLI JOSEPH
IPC: A01N25/30
Filed: 2006-04-06
Abstract: Disclosed is a two-part disinfecting system comprising a first part and a second part adapted to be mixed to yield an aqueous disinfecting composition, wherein the first part comprises a chlorite and the second part comprises an acid, and wherein the first part, the second part, or both the first and second parts contain an olefin compound effective at reducing chlorine dioxide generation having the formula: (R1)CH=CH(R2)(X) where R1 = [[H-]], CH3- ,CH3(CH2)n- , CH3(CH2)nCH(OH)- , and MO2C(CH2)n- ; n = 1-20; R2 = --(CH2)m- ,- CH(CH2)mCO2M; m= 2-20; M = H, Na, K, Ca, Mg, ammonia, or an organic cation; and X = a hydrophilic group having at least four heteroatoms selected from the group consisting of oxygen, nitrogen, sulfur, chlorine, bromine, fluorine, iodine, phosphorous and mixtures thereof, wherein there are at least two saturated carbon atoms between (R1)CH=CH and a heteroatom and a saturated carbon is a carbon free of double and triple bonds and the olefin compound is present in the first part, the second part, or both the first part and second part so that, when the first part and the second part are combined, the olefin compound is present within the disinfecting composition at a concentration ranging from about 0.005% to about 50% by weight, and wherein the acid is present in the second part in an amount so that, when combined with the first part, the pH of the disinfecting composition is between about 2 and about 5.
Patent NZ-561373-A (NZ)
Title: Composite secondary carpet backing, method of manufacture thereof, and carpet made therefrom
Inventor: GARDNER HUGH C
IPC: A47G27/00
Filed: 2006-02-27
Abstract: A carpet 700 consisting of a primary backing 705, face yarn consisting of a plurality of filaments tufted through the primary backing, and a binder layer 710 adhering a stitched side of the primary backing 705 to a secondary backing 300, the secondary backing 300 consisting of a woven fabric layer 405 having a flat weave which comprises at least one of a plain, satin, and twill weave construction of tape yarns in a warp direction interwoven with multifilament yarns in a filling direction, the woven fabric layer 405 having an open area of about 15% or less, the multifilament yarns having a thickness that is at least three times the thickness of warp tapes such that gaps are formed at crossover regions formed by the multifilament yarns and warp tapes, and a fibrous layer 510, where the fibrous layer 510 weighs between about 0.5 osy (0.169 gsm) and about 10 osy (3.39 gsm), and where at least a portion of the fibers 410 have penetrated through the woven fabric layer 405 and extend outward from a side thereof and wherein the secondary backing 300 has an air permeability of greater than about 220 cfm/sq ft (67 m3/min/m2).
Patent NZ-565059-A (NZ)
Title: Novel macrocyclic inhibitors of hepatitus C virus replication
Inventor: SEIWERT SCOTT D
IPC: A61P31/14
Filed: 2006-07-17
Abstract: Disclosed are compounds of formula (Ia), (Ib), (Ic) and (Id) wherein the substituents are as defined in the specification.  The compounds are useful in the treatment of Hepatitis C virus infection.
Patent NZ-565217-A (NZ)
Title: Melanocortin receptor ligands
Inventor: DONG ZHENG XIN
IPC: A61K38/04
Filed: 2006-07-10
Abstract: Disclosed is a melanocortin-4 selective receptor agonist compound according to the formula: Ac-Arg-c(Cys-D-Ala-His-D-Phe-Arg-Trp-Cys)-NH2 (SEQ ID NO: 50) or a pharmaceutically acceptable salt thereof.
Patent NZ-567869-A (NZ)
Title: Human resource management system
Inventor: CHANDLER KEVIN
Filed: 2008-05-02
Abstract: A computer system for recruitment selection, personnel management and career guidance, comprises: a database to store descriptions of jobs each of which is defined by one or more required competencies; a database to store descriptions of candidates each of which is defined by one or more candidate competencies; a processor selectively operable to identify and rank matches between a single job and many candidates based on required and candidate competencies, or to identify and rank matches between a single candidate and many jobs based on required and candidate competencies; and, a user interface to display a report comprising the ranked matches.
Patent NZ-570261-A (NZ)
Title: Carton with dispenser that is hinged in two places with gussets between sides and ends
Inventor: SUTHERLAND ROBERT L
IPC: B65D5/24
Filed: 2007-02-05
Abstract: A carton (190) for containing a plurality of articles (C) is disclosed. The carton (190) has sides (76a, 76b), of which at least one opens to form a dispensing opening (81a, 81b) that pivot outwards. The sides that open (76a, 76b) are hinged at the bottom and connected to the ends (12a) of the carton (190) by folding gussets (70b). The dispensing openings (81a, 81b) are opened by using a tear line on the top of the carton (190) the tear line partly defining a handle (100).
Patent NZ-583956-A (NZ)
Title: Method and reagent for measuring nitroreductase enzyme activity
Inventor: WEST RICHARD MARTIN
IPC: C12Q1/32
Filed: 2005-05-24
Abstract: Disclosed are highly conjugated compounds of formulas (II), (III), and (IV), where the substituents are as defined in the specification. Also disclosed is the use of the compounds as a substrate for the detection or measurement of nitroreductase enzyme activity.
Patent NZ-584759-A (NZ)
Title: Fungicidal compositions containing cyprodinil and fluazinam
Inventor: FORSTER BIRGIT
IPC: A01N43/78
Filed: 2006-09-27
Abstract: Disclosed is a composition for control of diseases on useful plants or on propagation material thereof caused by phytopathogens, that, in addition to customary inert formulation adjuvants, comprises as active ingredient a mixture of Cyprodinil and Fluazinam in a synergistically effective amount. Further disclosed is a method of controlling diseases on useful plants or on propagation material thereof caused by phytopathogens, which comprises applying to the useful plants, the locus thereof or propagation material thereof a composition as defined above.
Patent NZ-585529-A (NZ)
Title: Novel naphthyridine derivative monohydrate and method for producing the same
Inventor: KIYOTO TARO
IPC: C07D309/40
Filed: 2008-11-25
Abstract: Disclosed herein is 1-(2-(4-((2,3-dihydro(1,4)dioxino(2,3-c)pyridine-7-ylmethyl)amino)piperidin-1-yl)ethyl)-7-fluoro-1,5-naphthyridin-2(1H)-one monohydrate as given by the depicted formula. A method for the production for said compound is also further disclosed according to general [Production method 4], wherein the naphthyridine derivative compound as represented by [formula 7] is produced by the combination of [production method 1] and [Production Method 2], and the piperidine derivative represented by [Formula 17] is produced according to [Production Method 3], are reacted together to give the title compound.
Patent NZ-585555-A (NZ)
Title: Transgenic chicken containing a transgene comprising a glycosyltransferase coding sequence
Inventor: HARVEY ALEX J
IPC: A01K67/027
Filed: 2009-01-07
Abstract: Disclosed is a transgenic chicken containing a transgene comprising a glycosyltransferase coding sequence wherein oviduct tissue of the transgenic avian produces a protein having an N-linked oligosaccharide comprising at least one saccharide wherein the oligosaccharide would not comprise the saccharide in the absence of the trans gene.
Patent NZ-585837-A (NZ)
Title: A drive connection between a motor and a wheel using a lobed adaptor plate recessed into the hub of the wheel
Inventor: QUIRKE PETER
IPC: F16D1/04
Filed: 2010-06-02
Abstract: A timber-working head is disclosed. The head has a first motor (40-1), a second motor (40-2), a feed wheel (30), and an adaptor plate (50). The first motor includes a first rotary output element (48). The second motor includes a second rotary output element (48). The feed wheel is fixed to the first rotary output element and rotates with it. The adaptor plate is fixed to the second rotary output element and also rotates with it. The adaptor plate has radial projections (70) arranged about the periphery of the adaptor plate and received respectively within corresponding axially recessed portions (72) of the feed wheel so as to provide an operational interface between the adaptor plate and the feed wheel. This allows for ease of maintenance over prior art methods for connecting a feed head to a drive source.
Patent NZ-589006-A (NZ)
Title: Use of natural killer (NK) cells as a biomarker for patients that will respond to cancer treatment
Inventor: ACRES BRUCE
IPC: C12N5/0783
Filed: 2009-05-27
Abstract: A method for testing whether a patient will respond therapeutically to administration of an immunogenic composition or for predicting whether a patient will survive longer after administration of an immunogenic composition. The method comprises the step of: - Measuring the levels of activated Natural Killer (NK) cells in a blood sample from the patient, wherein low levels of activated NK cells indicate that the patient will develop a prophylactic or therapeutic immune response towards the immunogenic composition or that the patient will have a longer survival rate. Low levels of activated NK cells is less than about 5% of peripheral blood lymphocytes which express CD16, CD56 and CD96 surface antigens.
Patent NZ-594486-A (NZ)
Title: Narcotic emulsion opioid analgesic formulations for treatment of cancer pain
Inventor: NABETA KIICHIRO
IPC: A01N37/12
Filed: 2010-01-11
Abstract: 594486 NARCOTIC EMULSION FORMULATIONS FOR TREATMENT OF CANCER PAIN Provided is an intravenous narcotic emulsion formulation effective for use in treatment of cancer pain, wherein said narcotic emulsion formulation comprises: fentanyl; oil; water; a surfactant; and an emulsification enhancer.
Patent NZ-598913-A (NZ)
Title: Combination of an MEK inhibitor and a B-Raf inhibitor for the treatment of cancer
Inventor: LAQUERRE SYLVIE
IPC: A01N43/90
Filed: 2010-10-15
Abstract: ABSTRACT - 598913 The disclosure relates to the use of a combination comprising the MEK inhibitor N-{ 3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethyl;-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl} acetamide represented by formula (I) or a pharmaceutically acceptable salt or solvate thereof, with a B-Raf inhibitor, particularly N-{ 3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl} -2,6-difluorobenzenesulfonamide represented by formula (II) or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment of cancer.
Patent NZ-599097-A (NZ)
Title: Chimeric antibodies specific for cd151 and use thereof in the treatment of cancer
Inventor: HAEUW JEAN-FRANCOIS
IPC: A61P35/00
Filed: 2010-10-08
Abstract: 599097 Disclosed is a chimeric antibody that binds to CD151 comprising a light chain and a heavy chain sequences DIVLSQSPASLALSLGQRATISCRASASVEYYGTSLMHWYQQKPGQPPKLLIYEASNVESGVPARFSGSGSGTDFSLNIHPVEEDDLAIYFCQQSRKAPYTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC and EVKLVESGGGLVQPGGSLKLSCAASGFTFSTYTMSWVRQTPEKRLEWVAYISSGGGTTYYPDTVKGRFTISRDNARNTLYLQMNSLKSEDTAMYYCATPRIGTGFAYWGQGTLVTVSAASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNST YRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK, respectively.
Patent NZ-599193-A (NZ)
Title: Siglec 15 antibodies in treating bone loss-related disease
Inventor: TREMBLAY GILLES BERNARD
IPC: G01N33/574
Filed: 2010-10-06
Abstract: Disclosed is an isolated antibody or antigen binding fragment thereof capable of specific binding to amino acids 20 to 259 of Sialic-acid-binding immunoglobulin-like lectin 15 (Siglec-15; SEQ ID NO: 2), wherein said antibody or antigen binding fragment thereof comprises a light chain variable domain comprising a sequence selected from the group consisting of a sequence at least 70% identical to SEQ ID NO: 38, a sequence at least 70% identical to SEQ ID NO: 42, a sequence at least 70% identical to SEQ ID NO: 46, a sequence at least 70% identical to SEQ ID NO: 50, a sequence at least 70% identical to SEQ ID NO: 54, a sequence at least 70% identical to SEQ ID NO: 58, a sequence at least 70% identical to SEQ ID NO: 62, and a sequence at least 70% identical to SEQ ID NO: 66, and wherein said antibody comprises a heavy chain variable domain comprising a sequence selected from the group consisting of a sequence at least 70% identical to SEQ ID NO: 40, a sequence at least 70% identical to SEQ ID NO: 44, a sequence at least 70% identical to SEQ ID NO: 48, a sequence at least 70% identical to SEQ ID NO: 52, a sequence at least 70% identical to SEQ ID NO: 56, a sequence at least 70% identical to SEQ ID NO: 60, a sequence at least 70% identical to SEQ ID NO: 64, and a sequence at least 70% identical to SEQ ID NO: 68, wherein the sequences are disclosed within the specification. Also disclosed is the use of the above-described antibody or antigen binding fragment thereof in the manufacture of a medicament for the treatment of bone loss, bone disease or bone resorption.
Patent NZ-600745-A (NZ)
Title: Lightweight gypsum products having enhanced water resistance
Inventor: FISHER ROBIN DANIEL
IPC: C04B28/16
Filed: 2010-12-02
Abstract: The product is produced from a settable aqueous calcium sulphate dispersion which has a water to solids ratio of less than 0.4 to 1, and has distributed throughout lightweight hollow bodies having water-impervious surfaces (such as expanded polystyrene beads). The dispersion contains a hydratable cement (such as calcium sulpho aluminate) present in 5-15% by weight of the settable solids, which is capable of hydration in the presence of the calcium sulphate dispersion. The hydratable cement is such that it reacts with excess water in the dispersion thereby enhancing the water resistance of the resulting product.
Patent NZ-600751-A (NZ)
Title: Maillard flavor compositions with polar solvents different from water and methods for making such compositions
Inventor: ROBERT FABIEN
IPC: A23L27/21
Filed: 2010-12-02
Abstract: Disclosed is a maillard flavour composition comprising a structured lipid phase, a polar solvent different from water or a mixture of polar solvents where at least one of the polar solvents is different form water, and at least one maillard reaction product, wherein said polar solvent is glycerol. Also disclosed is a method for making a maillard flavour composition comprising making a structured lipid phase comprising a continuous lipid phase comprising a lipid and a dispersed polar solvent phase where the polar solvent is different from water or is a mixture of polar solvents where at least one of the polar solvents is different form water, and which contains at least a first reactant having a free carbonyl group and a second reactant having an amino group available for reaction with the free carbonyl group on the first reactant, wherein said polar solvent is glycerol.
Patent NZ-601099-A (NZ)
Title: Use of vip3ab in combination with cry1ca for management of resistant insects
Inventor: NARVA KENNETH
IPC: A61K36/899
Filed: 2010-12-16
Abstract: Disclosed is a transgenic plant having trans genes encoding insecticidal proteins wherein the insecticidal proteins are a Vip3Ab insecticidal protein and a Cry1Ca insecticidal protein. Further disclosed is a transgenic plant cell, wherein said plant cell has a trans gene encoding a Vip3Ab insecticidal protein and a transgene encoding a Cry1Ca insecticidal protein, wherein said Vip3Ab insecticidal protein is at least 99% identical with the amino acid sequence of SEQ ID NO:1, and said Cry1Ca insecticidal protein is at least 99% identical with the amino acid sequence of SEQ ID NO:2.
Patent NZ-610592-A (NZ)
Title: Anti-il-23 antibodies
Inventor: BARRETT RACHEL REBECCA
IPC: C07K16/24
Filed: 2011-11-02
Abstract: Disclosed is an anti-IL-23p19 antibody or antigen-binding fragment thereof, wherein the antibody or antigen-binding fragment thereof comprises the heavy and light chains with the CDRs as disclosed in the specification. Also disclosed is a method for producing the antibody and its use in the treatment of an inflammatory disease, of an autoimmune disease, of a respiratory disease, of a metabolic disorder or of cancer.
Patent NZ-613592-A (NZ)
Title: Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
Inventor: TASLER STEFAN
IPC: C07D413/04
Filed: 2012-01-27
Abstract: The present disclosure relates to pyrazolyl isoxazole compounds of the general formula (I), and the pharmaceutically acceptable salt or solvate thereof, as anti-inflammatory and immunomodulatory agents. These compounds act as inhibitors of IL17 and IFN-gamma. The conditions that may be treated by the present compounds include: psoriasis, psoriatric arthritis, autoimmune thyroiditis, Grave’s disease, rheumatoid arthritis, vitiligo, Crohn’s disease, ulcerative colitis, inflammatory bowel disease, ankylosing spondylitis, diabetes type I, multiple sclerosis, celiac disease, systemic lupus erythematosus, uveitis, Behcet disease, atopic dermatitis, Lichen planus, Sjogren’s syndrome, spinal disc herniation, acne, Graft-versus-Host-Reaction, Host-versus-Graft-Reaction and osteoarthritis. Compounds of the disclosure include: methyl 3-(2-chloro-6-fluorophenyl)-5-(1-(2-fluorophenyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl)isoxazole-4-carboxylate, (3-(2-chloro-6-fluorophenyl)-5-(1-(2-fluorophenyl )-5-(trifluoromethyl)-1H-pyrazol-4-yl)isoxazol-4-yl)(piperidin-1-yl)methanone, (3-(2-chloro-6-fluorophenyl)-5-(1-(3-fluorophenyl)-5-( trifluoromethyl)-1H-pyrazol-4-yl)isoxazol-4-yl)(isoxazolidin-2-yl)methanone, S-methyl 3-(2-chloro-6-fluorophenyl)-5-(1-(3-fluorophenyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl)isoxazole-4-carbothioate, and (Z)-methyl N-(3-(2-chloro-6-fluorophenyl)-5-(1-(3 -fluorophenyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl)isoxazol-4-yl)-2,2,2-trifluoroacetimidate.
Patent NZ-620962-A (NZ)
Title: Method and apparatus for cartridge-based carbonation of beverages
Inventor: NOVAK THOMAS J
IPC: B67D3/00
Filed: 2012-08-02
Abstract: Systems, methods and cartridges for carbonating or otherwise dissolving gas in a precursor liquid, such as water, to form a beverage. A gas source (41) can be provided in a cartridge which is used to generate gas that is dissolved into the precursor liquid. A beverage medium (42), such as a powdered drink mix or liquid syrup, may be provided in the same, or a separate cartridge as the gas source (4) and mixed with the precursor liquid to form a beverage. The use of one or more cartridges for the gas source (41) and/or beverage medium (42) may make for an easy to use and mess-free system for making sparkling beverages, e.g., in the consumer’s home.
Patent NZ-706402-A (NZ)
Title: Rotary fastener magazine
Inventor: GOSIS ANATOLY
IPC: B27F7/13
Filed: 2009-08-31
Abstract: A fastener driving tool (10) including a housing (12) enclosing a power source, including a reciprocating piston (16) with a driver blade (18). A nosepiece (20) associated with the housing receives the driver blade (18) and sequentially receives fasteners (24) from a magazine (22) for driving into a work piece. The magazine (22) stores a plurality of elongate strips of fasteners (24) and rotates about a longitudinal axis to supply each strip to the nosepiece (20) when urged by a follower (52). The magazine has a keeper in the forward end (90) for retaining the fasteners (24) in the magazine.
Patent NZ-713659-A (NZ)
Title: Bubbling bed catalytic hydropyrolysis process utilizing larger catalyst particles and smaller biomass particles featuring an anti-slugging reactor
Inventor: MARKER TERRY L
IPC: C10G3/00
Filed: 2012-03-23
Abstract: Disclosed is a method for hydropyrolyzing an oxygenated organic feedstock, the method comprising: (a) introducing the oxygenated organic feedstock and a fluidizing gas comprising hydrogen into a fluidized bed hydropyrolysis reactor comprising a fluidized bed of solid particles, including catalyst, under hydropyrolysis conditions sufficient to generate product vapors from thermal decomposition and hydropyrolysis of the oxygenated organic feedstock; and (b) recovering from the product vapors a product stream containing substantially fully deoxygenated hydrocarbon species and less than about 4% oxygen by mass; wherein the fluidized bed of solid particles has a depth of greater than two reactor diameters and includes lateral inserts (200) selected from the group consisting of obstructions, obstacles, constrictions, and combinations thereof, spaced at axial intervals from about one to about two reactor diameters in a manner such that slugging does not occur within the fluidized bed hydropyrolysis reactor.
Patent NZ-714817-A (NZ)
Title: Coated particles and compositions comprising same
Inventor: CHAWRAI SURESH
IPC: A61Q19/00
Filed: 2014-06-03
Abstract: The invention provides species of lipid, protein, and/or cationic molecule coated active agents and compositions comprising the coated particles. The compositions can be personal care compositions such as anti-dandruff shampoo or conditioner, skin care compositions, creams, gels, toothpastes, mouth washes, and chewing gums.
Patent NZ-715837-A (NZ)
Title: 4-alkynyl imidazole derivative and medicine comprising same as active ingredient
Inventor: IKEGAMI SATORU
IPC: C07D413/12
Filed: 2014-06-12
Abstract: Provided are 4-alkynyl imidazole derivatives represented by general formula (I) and pharmacologically permissible salts thereof. The derivatives have excellent EP4 receptor antagonist effects and are useful as medicines for treating diseases associated with EP4 receptors, for example, anti-inflammatory agents and/or analgesics for inflammatory diseases and diseases associated with various kinds of pain, and also as medicines for treating immune diseases that occur as a result of Th1 cell and/or Th17 cell activation, which causes tissue destruction and gives rise to inflammation.
Patent NZ-720373-A (NZ)
Title: Impalement prevention apparatus for extending overtop of and around the exposed ends of a plurality of spaced-apart reinforcing bars
Inventor: HEWLETT PHIL
IPC: E04G21/32
Filed: 2014-11-03
Abstract: There is provided an impalement prevention apparatus for use with a plurality of spaced apart bars. The apparatus includes an elongate top portion shaped to extend overtop of exposed ends of the bars. The apparatus includes a pair of elongate spaced-apart side portions connecting to the top portion and extending downwards therefrom. The apparatus includes a pair of spaced-apart end portions each connecting to and extending between the side portions. The top portion, the side portions and the end portions form an enclosure extendable around the exposed ends of the bars. These features solves the issues of other impalement prevention apparatuses by being readily removable, re-usable, and stackable. The apparatus’s tapered side walls also solves the issue of sliding and exposing the bars when a person falls on to the apparatus.
Patent NZ-723369-A (NZ)
Title: Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
Inventor: SEXTON DANIEL
IPC: G01N33/53
Filed: 2015-01-21
Abstract: Provided herein are plasma kallikrein binding proteins such as the antibody DX-2930 (SEQ ID NO: 5-10) at a dose of 300mg every 2-4 weeks that binds to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.